Experienced in Neuralgia

Dr. James P. Wymer

Neurology
Florida Clinical Practice Association Inc
Uf Health Test Site Pop Up 1600 Sw Archer Rd, 
Gainesville, FL 
Accepting New Patients
Offers Telehealth
Experienced in Neuralgia
Florida Clinical Practice Association Inc
Uf Health Test Site Pop Up 1600 Sw Archer Rd, 
Gainesville, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

James Wymer is a Neurologist in Gainesville, Florida. Dr. Wymer is rated as an Experienced provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal Muscular Atrophy Type 3, Spinal and Bulbar Muscular Atrophy, and Gastrostomy. Dr. Wymer is currently accepting new patients.

His clinical research consists of co-authoring 59 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Neuralgia.

Specialties
Neurology
Licenses
Psychiatry & Neurology in NY
Hospital Affiliations
Uf Health Shands Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Health First
  • HMO
  • POS
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

FLORIDA CLINICAL PRACTICE ASSOCIATION INC
Uf Health Test Site Pop Up 1600 Sw Archer Rd, Gainesville, FL 32610
Other Locations
FLORIDA CLINICAL PRACTICE ASSOCIATION INC
3009 Sw Williston Rd, Uf Health Digestive Diseas, Gainesville, FL 32608
FLORIDA CLINICAL PRACTICE ASSOCIATION INC
2000 Sw Archer Rd, Uf Health Congenital Heart, Gainesville, FL 32610
FLORIDA CLINICAL PRACTICE ASSOCIATION INC
2001 Sw 13th St, Gi Clinic At Endoscopy Cen, Gainesville, FL 32608

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Pragmatic Trial to Evaluate the Intermediate-term Effects of Early, Aggressive Versus Escalation Therapy in People With Multiple Sclerosis
A Pragmatic Trial to Evaluate the Intermediate-term Effects of Early, Aggressive Versus Escalation Therapy in People With Multiple Sclerosis
Enrollment Status: Active_not_recruiting
Publish Date: October 14, 2025
Intervention Type: Other
Study Phase: Not Applicable
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Participants With Painful Diabetic Peripheral Neuropathy
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Participants With Painful Diabetic Peripheral Neuropathy
Enrollment Status: Completed
Publish Date: October 09, 2025
Intervention Type: Other, Biological
Study Phase: Phase 3
Long-term, Prospective, Non-interventional, Extension of a Phase III, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety & Efficacy of Engensis (VM202) in Subjects With Painful Diabetic Peripheral Neuropathy
Long-term, Prospective, Non-interventional, Extension of a Phase III, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety & Efficacy of Engensis (VM202) in Subjects With Painful Diabetic Peripheral Neuropathy
Enrollment Status: Completed
Publish Date: October 09, 2025
Intervention Type: Drug, Genetic
Study Phase: Phase 3
A Single-Center, Open Label Study to Assess the Safety and Tolerability of Metformin in Subjects With C9orf72 Amyotrophic Lateral Sclerosis Over 24 Weeks of Treatment
A Single-Center, Open Label Study to Assess the Safety and Tolerability of Metformin in Subjects With C9orf72 Amyotrophic Lateral Sclerosis Over 24 Weeks of Treatment
Enrollment Status: Active_not_recruiting
Publish Date: August 01, 2025
Intervention Type: Drug
Study Drug: Metformin
Study Phase: Phase 2
Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS
Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Other, Drug
Study Phase: Phase 2
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
Enrollment Status: Active_not_recruiting
Publish Date: April 03, 2024
Intervention Type: Drug
Study Drug: (RS)-Baclofen, Naltrexone Hydrochloride and D-Sorbitol
Study Phase: Phase 3
An Open-Label Pilot Study to Assess Potential Mechanisms for Fibromyalgia in Peripheral Tissue Innervation That Could Predict Therapeutic Responsiveness to Milnacipran
An Open-Label Pilot Study to Assess Potential Mechanisms for Fibromyalgia in Peripheral Tissue Innervation That Could Predict Therapeutic Responsiveness to Milnacipran
Enrollment Status: Completed
Publish Date: January 09, 2020
Intervention Type: Drug, Procedure
Study Phase: Phase 4
A Multi-Center, Open Label Study to Assess the Safety and Tolerability of Riluzole Oral Soluble Film in Subjects With Amyotrophic Lateral Sclerosis Over 12 Weeks of Twice Daily Treatment.
A Multi-Center, Open Label Study to Assess the Safety and Tolerability of Riluzole Oral Soluble Film in Subjects With Amyotrophic Lateral Sclerosis Over 12 Weeks of Twice Daily Treatment.
Enrollment Status: Withdrawn
Publish Date: May 13, 2019
Intervention Type: Drug
Study Phase: Phase 2
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Enrollment Status: Completed
Publish Date: July 06, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 8 Less Clinical Trials

59 Total Publications

Risk prediction for ALS using semi-competing risk models with applications to the ALS Natural History Consortium dataset.
Risk prediction for ALS using semi-competing risk models with applications to the ALS Natural History Consortium dataset.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: May 14, 2025
Similar Doctors
Advanced in Neuralgia
Dr. Jose A. Gaudier
Neurology
Advanced in Neuralgia
Dr. Jose A. Gaudier
Neurology

Dr. Jose Gaudier, M.D., P.A. Neurology

1740 SE 18th Street, Suite 1202, 
Ocala, FL 
 (35.3 miles away)
352-732-8630
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jose Gaudier is a Neurologist in Ocala, Florida. Dr. Gaudier is rated as a Distinguished provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Apraxia, Migraine with Brainstem Aura, Essential Tremor, and Memory Loss. Dr. Gaudier is currently accepting new patients.

Advanced in Neuralgia
Dr. Lance Y. Kim
Neurology
Advanced in Neuralgia
Dr. Lance Y. Kim
Neurology

Dr. Lance Kim

2237 SW 19th Avenue Rd, 
Ocala, FL 
 (34.5 miles away)
352-867-9877
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lance Kim is a Neurologist in Ocala, Florida. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Idiopathic Hypersomnia, Narcolepsy, Hereditary Neuralgic Amyotrophy, and Obstructive Sleep Apnea. Dr. Kim is currently accepting new patients.

Advanced in Neuralgia
Dr. Alexander J. Smirnoff
Neurology
Advanced in Neuralgia
Dr. Alexander J. Smirnoff
Neurology

Cora Health Services, Inc.

11962 County Rd, 101 Suite 104, 
The Villages, FL 
 (52.0 miles away)
352-693-3378
Languages Spoken:
English
See accepted insurances

Alexander Smirnoff is a Neurologist in The Villages, Florida. Dr. Smirnoff is rated as a Distinguished provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Cerebellar Degeneration, Foot Drop, Essential Tremor, and Diabetic Neuropathy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wymer's expertise for a condition
ConditionClose
View All 39 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile